nitroglycerin has been researched along with Adenocarcinoma, Basal Cell in 7 studies
Nitroglycerin: A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium. It is also sometimes used for TOCOLYSIS and explosives.
nitroglycerol : A nitrate ester that is glycerol in which nitro group(s) replace the hydrogen(s) attached to one or more of the hydroxy groups.
nitroglycerin : A nitroglycerol that is glycerol in which the hydrogen atoms of all three hydroxy groups are replaced by nitro groups. It acts as a prodrug, releasing nitric oxide to open blood vessels and so alleviate heart pain.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Seventeen patients with operable lung adenocarcinoma and stable angina pectoris were selected to investigate the effects of nitroglycerin on immunoreactivity for hypoxia-inducible factor 1alpha (HIF-1alpha), vascular endothelial growth factor (VEGF), P-glycoprotein (P-gp), the production of which is regulated by HIF-1, and p53 proteins in their resected tumor by semiquantitative immunohistochemical analyses." | 9.12 | Nitroglycerin treatment may enhance chemosensitivity to docetaxel and carboplatin in patients with lung adenocarcinoma. ( Asada, M; Fuji, H; Inoue, D; Kanda, A; Kaneta, T; Kondo, T; Nakayama, K; Okinaga, S; Sasaki, H; Sasaki, T; Suzuki, S; Suzuki, T; Takai, Y; Watanabe, M; Yamanda, S; Yamaya, M; Yanagihara, K; Yasuda, H; Yoshida, M; Zayasu, K, 2006) |
| "Seventeen patients with operable lung adenocarcinoma and stable angina pectoris were selected to investigate the effects of nitroglycerin on immunoreactivity for hypoxia-inducible factor 1alpha (HIF-1alpha), vascular endothelial growth factor (VEGF), P-glycoprotein (P-gp), the production of which is regulated by HIF-1, and p53 proteins in their resected tumor by semiquantitative immunohistochemical analyses." | 5.12 | Nitroglycerin treatment may enhance chemosensitivity to docetaxel and carboplatin in patients with lung adenocarcinoma. ( Asada, M; Fuji, H; Inoue, D; Kanda, A; Kaneta, T; Kondo, T; Nakayama, K; Okinaga, S; Sasaki, H; Sasaki, T; Suzuki, S; Suzuki, T; Takai, Y; Watanabe, M; Yamanda, S; Yamaya, M; Yanagihara, K; Yasuda, H; Yoshida, M; Zayasu, K, 2006) |
| "Hypoxia is also associated with human prostate cancers, which are highly resistant to chemotherapy." | 1.32 | Hypoxia induced resistance to doxorubicin in prostate cancer cells is inhibited by low concentrations of glyceryl trinitrate. ( Adams, MA; Frederiksen, LJ; Graham, CH; Heaton, JP; Maxwell, LR; Siemens, DR, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Illum, H | 1 |
| Wang, DH | 1 |
| Dowell, JE | 1 |
| Hittson, WJ | 1 |
| Torrisi, JR | 1 |
| Meyer, J | 1 |
| Huerta, S | 1 |
| Siemens, DR | 2 |
| Hu, N | 1 |
| Sheikhi, AK | 1 |
| Chung, E | 1 |
| Frederiksen, LJ | 2 |
| Pross, H | 1 |
| Graham, CH | 2 |
| Nagai, H | 1 |
| Yasuda, H | 2 |
| Hatachi, Y | 1 |
| Xue, D | 1 |
| Sasaki, T | 2 |
| Yamaya, M | 2 |
| Sakamori, Y | 1 |
| Togashi, Y | 1 |
| Masago, K | 1 |
| Ito, I | 1 |
| Kim, YH | 1 |
| Mio, T | 1 |
| Mishima, M | 1 |
| Heaton, JP | 1 |
| Maxwell, LR | 1 |
| Adams, MA | 1 |
| Nakayama, K | 1 |
| Watanabe, M | 1 |
| Suzuki, S | 1 |
| Fuji, H | 1 |
| Okinaga, S | 1 |
| Kanda, A | 1 |
| Zayasu, K | 1 |
| Asada, M | 1 |
| Suzuki, T | 1 |
| Yoshida, M | 1 |
| Yamanda, S | 1 |
| Inoue, D | 1 |
| Kaneta, T | 1 |
| Kondo, T | 1 |
| Takai, Y | 1 |
| Sasaki, H | 1 |
| Yanagihara, K | 1 |
| Lagergren, J | 1 |
| Bergström, R | 1 |
| Adami, HO | 1 |
| Nyrén, O | 1 |
| Kontturi, M | 1 |
| Sotaniemi, E | 1 |
| Ahlqvist, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effects of Exercise Training on Tumor Vascularity and Response to Neoadjuvant Therapy in Operable Breast Cancer: A Phase I-II Study[NCT00405678] | Phase 1/Phase 2 | 23 participants (Actual) | Interventional | 2006-09-30 | Completed | ||
| A Prospective Study To Define The Role Of Various Factors In Development And Progression Of Gastroesophageal Reflux Disease (GERD) And Barrett's Esophagus And The Creation Of A Registry.[NCT00574327] | 3,000 participants (Anticipated) | Observational | 2006-01-31 | Recruiting | |||
| Barrett's Esophagus Study (BEST) Trial - a Multi-Center and Endoscopic Outcomes Project[NCT00586404] | 1,250 participants (Actual) | Observational | 2007-11-30 | Terminated (stopped due to lack of enrollment) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for nitroglycerin and Adenocarcinoma, Basal Cell
| Article | Year |
|---|---|
Phase I dose escalation trial of nitroglycerin in addition to 5-fluorouracil and radiation therapy for neoadjuvant treatment of operable rectal cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; | 2015 |
Nitroglycerin treatment may enhance chemosensitivity to docetaxel and carboplatin in patients with lung adenocarcinoma.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; ATP Binding | 2006 |
5 other studies available for nitroglycerin and Adenocarcinoma, Basal Cell
| Article | Year |
|---|---|
Hypoxia increases tumor cell shedding of MHC class I chain-related molecule: role of nitric oxide.
Topics: Adenocarcinoma; Animals; Cells, Cultured; Histocompatibility Antigens Class I; Humans; Hypoxia; Immu | 2008 |
Nitric oxide (NO) enhances pemetrexed cytotoxicity via NO‑cGMP signaling in lung adenocarcinoma cells in vitro and in vivo.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Antineoplastic Combined Chemotherapy Protocols; Apo | 2012 |
Hypoxia induced resistance to doxorubicin in prostate cancer cells is inhibited by low concentrations of glyceryl trinitrate.
Topics: Adenocarcinoma; Blotting, Western; Cell Cycle; Doxorubicin; Drug Resistance, Neoplasm; Flow Cytometr | 2003 |
Association between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma.
Topics: Adenocarcinoma; Adrenergic beta-Agonists; Aminophylline; Benzodiazepines; Carcinoma, Squamous Cell; | 2000 |
Association between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma.
Topics: Adenocarcinoma; Adrenergic beta-Agonists; Aminophylline; Benzodiazepines; Carcinoma, Squamous Cell; | 2000 |
Association between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma.
Topics: Adenocarcinoma; Adrenergic beta-Agonists; Aminophylline; Benzodiazepines; Carcinoma, Squamous Cell; | 2000 |
Association between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma.
Topics: Adenocarcinoma; Adrenergic beta-Agonists; Aminophylline; Benzodiazepines; Carcinoma, Squamous Cell; | 2000 |
Liver damage and estrogen therapy of prostatic cancer. Case report.
Topics: Adenocarcinoma; Aged; Blood Glucose; Carbutamide; Diabetes Mellitus; Diethylstilbestrol; Digoxin; Dr | 1972 |